pediatrix medical group inc. - MD

MD

Close Chg Chg %
21.38 -0.22 -1.03%

Open Market

21.16

-0.22 (1.03%)

Volume: 309.09K

Last Updated:

Apr 1, 2026, 12:19 PM EDT

Company Overview: pediatrix medical group inc. - MD

MD Key Data

Open

$21.30

Day Range

21.07 - 21.46

52 Week Range

11.84 - 24.99

Market Cap

$1.78B

Shares Outstanding

83.00M

Public Float

81.66M

Beta

0.72

Rev. Per Employee

N/A

P/E Ratio

11.03

EPS

$1.96

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

936.26K

 

MD Performance

1 Week
 
4.34%
 
1 Month
 
7.76%
 
3 Months
 
0.00%
 
1 Year
 
58.33%
 
5 Years
 
-15.62%
 

MD Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 7
Full Ratings ➔

About pediatrix medical group inc. - MD

Pediatrix Medical Group, Inc. engages in the provision of physician services. Its services include neonatal care, maternal fetal care, and other pediatric subspeciality care. The company was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.

MD At a Glance

Pediatrix Medical Group, Inc.
1301 Concord Terrace
Sunrise, Florida 33323
Phone 1-954-384-0175 Revenue 1.91B
Industry Medical/Nursing Services Net Income 165.39M
Sector Health Services Employees 6,575
Fiscal Year-end 12 / 2026
View SEC Filings

MD Valuation

P/E Current 11.028
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 11.028
Price to Sales Ratio 0.953
Price to Book Ratio 2.05
Price to Cash Flow Ratio 6.73
Enterprise Value to EBITDA 7.745
Enterprise Value to Sales 1.023
Total Debt to Enterprise Value 0.324

MD Efficiency

Revenue/Employee 291,079.696
Income Per Employee 25,154.068
Receivables Turnover 7.898
Total Asset Turnover 0.87

MD Liquidity

Current Ratio 1.664
Quick Ratio 1.664
Cash Ratio 1.089

MD Profitability

Gross Margin 24.656
Operating Margin 12.074
Pretax Margin 11.309
Net Margin 8.642
Return on Assets 7.519
Return on Equity 20.283
Return on Total Capital 11.022
Return on Invested Capital 11.581

MD Capital Structure

Total Debt to Total Equity 73.294
Total Debt to Total Capital 42.294
Total Debt to Total Assets 28.247
Long-Term Debt to Equity 68.859
Long-Term Debt to Total Capital 39.735
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Pediatrix Medical Group Inc. - MD

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
1.97B 1.99B 2.01B 1.91B
Sales Growth
+3.18% +1.15% +0.92% -4.92%
Cost of Goods Sold (COGS) incl D&A
1.54B 1.61B 1.59B 1.44B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
35.64M 36.17M 32.23M 21.83M
Depreciation
26.70M 28.10M 22.70M 14.30M
Amortization of Intangibles
8.94M 8.07M 9.53M 7.53M
COGS Growth
+7.73% +4.45% -1.15% -9.36%
Gross Income
431.40M 385.39M 422.12M 471.88M
Gross Income Growth
-10.33% -10.66% +9.53% +11.79%
Gross Profit Margin
+21.88% +19.32% +20.97% +24.66%
2022 2023 2024 2025 5-year trend
SG&A Expense
231.40M 227.54M 238.44M 240.79M
Research & Development
- - - -
-
Other SG&A
231.40M 227.54M 238.44M 240.79M
SGA Growth
-12.14% -1.67% +4.79% +0.99%
Other Operating Expense
- - - -
-
Unusual Expense
84.33M 170.53M 242.69M 22.27M
EBIT after Unusual Expense
115.67M (12.68M) (59.01M) 208.81M
Non Operating Income/Expense
5.39M 6.39M (1.58M) 43.58M
Non-Operating Interest Income
3.67M 4.34M 5.77M 19.05M
Equity in Earnings of Affiliates
1.72M 2.06M 2.34M 3.63M
Interest Expense
39.70M 42.08M 40.74M 35.97M
Interest Expense Growth
-42.24% +6.00% -3.17% -11.73%
Gross Interest Expense
39.70M 42.08M 40.74M 35.97M
Interest Capitalized
- - - -
-
Pretax Income
81.37M (48.36M) (101.34M) 216.43M
Pretax Income Growth
-39.83% -159.43% -109.56% +313.57%
Pretax Margin
+4.13% -2.42% -5.03% +11.31%
Income Tax
18.81M 12.05M (2.27M) 51.04M
Income Tax - Current - Domestic
41.58M 8.81M (142.00K) (1.14M)
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(22.77M) 3.24M (2.13M) 52.19M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
1.72M 2.06M 2.34M 3.63M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
62.56M (60.41M) (99.07M) 165.39M
Minority Interest Expense
- - - (4.00K)
-
Net Income
62.57M (60.41M) (99.07M) 165.39M
Net Income Growth
-42.07% -196.55% -64.00% +266.94%
Net Margin Growth
+3.17% -3.03% -4.92% +8.64%
Extraordinaries & Discontinued Operations
- - - 3.77M
-
Discontinued Operations
- - - 3.77M
-
Net Income After Extraordinaries
66.33M (60.41M) (99.07M) 165.39M
Preferred Dividends
- - - -
-
Net Income Available to Common
66.33M (60.41M) (99.07M) 165.39M
EPS (Basic)
0.7948 -0.7349 -1.1889 1.967
EPS (Basic) Growth
-48.52% -192.46% -61.78% +265.45%
Basic Shares Outstanding
83.47M 82.20M 83.33M 84.08M
EPS (Diluted)
0.7886 -0.7349 -1.1889 1.9396
EPS (Diluted) Growth
-48.32% -193.19% -61.78% +263.14%
Diluted Shares Outstanding
84.12M 82.20M 83.33M 85.27M
EBITDA
235.64M 194.02M 215.91M 252.91M
EBITDA Growth
-5.70% -17.66% +11.28% +17.14%
EBITDA Margin
+11.95% +9.73% +10.73% +13.21%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 21.20
Number of Ratings 7 Current Quarters Estimate 0.592
FY Report Date 06 / 2026 Current Year's Estimate 2.235
Last Quarter’s Earnings 0.374 Median PE on CY Estimate N/A
Year Ago Earnings 2.04 Next Fiscal Year Estimate 2.326
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 7 7 7 6
Mean Estimate 0.59 0.68 2.24 2.33
High Estimates 0.64 0.79 2.36 2.57
Low Estimate 0.56 0.61 2.16 2.12
Coefficient of Variance 5.12 8.79 3.80 6.38

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 2 2 2
OVERWEIGHT 0 0 0
HOLD 5 5 5
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Pediatrix Medical Group Inc. in the News